Your browser doesn't support javascript.
loading
Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid.
Foster, Alison J; Chouhan, Bhavik; Regan, Sophie L; Rollison, Helen; Amberntsson, Sara; Andersson, Linda C; Srivastava, Abhishek; Darnell, Malin; Cairns, Jonathan; Lazic, Stanley E; Jang, Kyung-Jin; Petropolis, Debora B; Kodella, Konstantia; Rubins, Jonathan E; Williams, Dominic; Hamilton, Geraldine A; Ewart, Lorna; Morgan, Paul.
Afiliação
  • Foster AJ; Drug Safety and Metabolism, AstraZeneca IMED Biotech Unit, Cambridge, CB4 0WG, UK. alison.foster2@astraeneca.com.
  • Chouhan B; Drug Safety and Metabolism, AstraZeneca IMED Biotech Unit, Gothenburg, 431 83, Sweden.
  • Regan SL; Drug Safety and Metabolism, AstraZeneca IMED Biotech Unit, Cambridge, CB4 0WG, UK.
  • Rollison H; Drug Safety and Metabolism, AstraZeneca IMED Biotech Unit, Cambridge, CB4 0WG, UK.
  • Amberntsson S; Drug Safety and Metabolism, AstraZeneca IMED Biotech Unit, Gothenburg, 431 83, Sweden.
  • Andersson LC; Drug Safety and Metabolism, AstraZeneca IMED Biotech Unit, Gothenburg, 431 83, Sweden.
  • Srivastava A; Drug Safety and Metabolism, AstraZeneca IMED Biotech Unit, Cambridge, CB4 0WG, UK.
  • Darnell M; Drug Safety and Metabolism, AstraZeneca IMED Biotech Unit, Gothenburg, 431 83, Sweden.
  • Cairns J; Discovery Sciences, AstraZeneca IMED Biotech Unit, Cambridge, UK.
  • Lazic SE; Discovery Sciences, AstraZeneca IMED Biotech Unit, Cambridge, UK.
  • Jang KJ; Emulate, Inc, 27, Drydock Ave, 02210, Boston, MA, US.
  • Petropolis DB; Emulate, Inc, 27, Drydock Ave, 02210, Boston, MA, US.
  • Kodella K; Emulate, Inc, 27, Drydock Ave, 02210, Boston, MA, US.
  • Rubins JE; Emulate, Inc, 27, Drydock Ave, 02210, Boston, MA, US.
  • Williams D; Drug Safety and Metabolism, AstraZeneca IMED Biotech Unit, Cambridge, CB4 0WG, UK.
  • Hamilton GA; Emulate, Inc, 27, Drydock Ave, 02210, Boston, MA, US.
  • Ewart L; Drug Safety and Metabolism, AstraZeneca IMED Biotech Unit, Cambridge, CB4 0WG, UK.
  • Morgan P; Drug Safety and Metabolism, AstraZeneca IMED Biotech Unit, Cambridge, CB4 0WG, UK.
Arch Toxicol ; 93(4): 1021-1037, 2019 04.
Article em En | MEDLINE | ID: mdl-30915487
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esferoides Celulares / Hepatócitos / Doença Hepática Induzida por Substâncias e Drogas / Fígado / Modelos Biológicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esferoides Celulares / Hepatócitos / Doença Hepática Induzida por Substâncias e Drogas / Fígado / Modelos Biológicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article